Claudia Berger
Solvay
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claudia Berger.
Biochemical and Biophysical Research Communications | 2003
Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys
Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.
British Journal of Pharmacology | 2003
Hans-Peter Lammerich; Annette Busmann; Christian Kutzleb; Martin Wendland; Petra Seiler; Claudia Berger; Peter Eickelmann; Markus Meyer; Wolf-Georg Forssmann; Erik Maronde
The human orphan G‐protein coupled receptor bombesin receptor subtype 3 (hBRS‐3) was screened for peptide ligands by a Ca2+ mobilization assay resulting in the purification and identification of two specific ligands, the naturally occurring VV‐hemorphin‐7 (VV‐H‐7) and LVV‐hemorphin‐7 (LVV‐H‐7), from human placental tissue. These peptides were functionally characterized as full agonists with unique specificity albeit low affinity for hBRS‐3 compared to other bombesin receptors. VV‐H‐7 and LVV‐H‐7 induced a dose‐dependent response in hBRS‐3 overexpressing CHO cells, as well as in NCI‐N417 cells expressing the hBRS‐3 endogenously. The affinity of VV‐H‐7 was higher in NCI‐N417 cells compared to overexpressing CHO cells. In detail, the EC50 values were 45±15 μM for VV‐H‐7 and 183±60 μM for LVV‐H‐7 in CHO cells, and 19±6 μM for VV‐H‐7 and 38±18 μM for LVV‐H‐7 in NCI‐N417 cells. Other hemorphins had no effect. Gastrin‐releasing peptide (GRP) and neuromedin B (NMB) showed similar EC50 values of 13–20 μM (GRP) and of 1–2 μM (NMB) on both cell lines. Structure‐function analysis revealed that both the N‐terminal valine and the C‐terminal phenylalanine residues of VV‐H‐7 are critical for the ligand‐receptor interaction. Endogenous hBRS‐3 in NCI‐N417 activated by VV‐H‐7 couples to phospholipase C resulting in changes of intracellular calcium, which is initially released from an inositol trisphosphate (IP3)‐sensitive store followed by a capacitive calcium entry from extracellular space. VV‐H‐7‐induced hBRS‐3 activation led to phosphorylation of p42/p44‐MAP kinase in NCI‐N417 cells, but did not stimulate cell proliferation. In contrast, phosphorylation of focal adhesion kinase (p125FAK) was not observed.
Journal of Medicinal Chemistry | 2003
Dirk Weber; Claudia Berger; Peter Eickelmann; Jochen Antel; Horst Kessler
Journal of Peptide Science | 2002
Dirk Weber; Claudia Berger; Timo Heinrich; Peter Eickelmann; Jochen Antel; Horst Kessler
Archive | 2004
Dirk Weber; Horst Kessler; Claudia Berger; Jochen Antel; Timo Heinrich
Archive | 2002
Claudia Berger; Yvan Fischer; Dagmar Höltje; Harald Waldeck; Michael Weske; Dieter Ziegler
Archive | 2003
Claudia Berger; Yvan Fischer; Dagmar Hoeltje; Harald Waldeck; Michael Weske; Dieter Ziegler
Archive | 2004
Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys
Archive | 2005
Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys
Archive | 2005
Jakob Venema; Claudia Berger; Christiane Löken; Willy Deleersnijder; Guy Nys